跳至主要内容
临床试验/JPRN-UMIN000024786
JPRN-UMIN000024786已完成未知

A study to investigate effects of Peptide ingestion on lowering blood pressure in the subjects with high normal blood pressure or grade 1 hypertension: a randomized, double blind, placebo controlled study. - A study to assess the effects of Peptide ingestion on lowering blood pressure.

CROee.INC0 个研究点目标入组 120 人开始时间: 2016年11月21日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30years-old 至 65years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) Subjects who have history or receiving treatment of serious disease (2) Subject who is under medication for diabetes, hypertension or dyslipidemia (3) Subject with a history of serious allergy to medicine and food (4) Subject who is pregnant or under lactation, or who is expected to be pregnant during the study (5) Heavy smoker and heavy drinker, or subject with irregular lifestyle (6) Subject who is ineligible due to physician's judgment based on background of subject, physical finding, interview

研究者

发起方
CROee.INC

相似试验